Sammons Cancer Center - Texas Oncology SC-2 — Dallas, Texas

Sammons Cancer Center - Texas Oncology SC-2 is a clinical research site located in Dallas, Texas, United States 78246.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Sammons Cancer Center - Texas Oncology SC-2 has participated in 2 clinical trials.

Therapeutic areas: Dose Escalation, Safety, Preliminary Efficacy.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sammons Cancer Center - Texas Oncology SC-2?

Sammons Cancer Center - Texas Oncology SC-2 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sammons Cancer Center - Texas Oncology SC-2 conducted?

Sammons Cancer Center - Texas Oncology SC-2 has 2 clinical trials on record. Their work covers Dose Escalation, Safety, Preliminary Efficacy.

Is Sammons Cancer Center - Texas Oncology SC-2 accredited by Crixeo Health?

Sammons Cancer Center - Texas Oncology SC-2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sammons Cancer Center - Texas Oncology SC-2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.